Recent Articles

Stocks Drop on Biotech Blues

The markets took another turn for the worst as Citron Research calls out a former Wall Street darling as possibly the Enron of biotech. More 

All About Nothing: Stock ETFs Celebrate Zero Percent Rate Policy

Sector ETFs rocketed off recent intra-day lows as investors believed the Fed will not move soon to raise interest rates. Now what? More 

6 Gold Companies Creating Wealth Sooner Than You Think

In this Q&A, gold expert Jeb Handwerger provides insight into the state of the gold sector, and identifies major players for the future. More 

Stocks Drift Ahead of Yellen’s Thursday Speech

Despite Yellen's dovish remarks and no-hike decision, markets fell for the second consecutive day on weak China data and oil prices. More 

When a Down Market Isn’t (Necessarily) Bad

Recent market downturns are happening in a more orderly manner than the August route. It's a good sign for the long term More 

Stocks End Two-Month Rebound on Fed Fears

Nervous traders hit the brakes on Tuesday amid a day that saw Volkswagen's emissions equipment scandal put the hurt on Ford, GM and other auto stocks. More 

Turning a Bad ETF Investment Into Good

Do good performing investments always start out good? The short answer is not necessarily. At times the key to successful investing is the long-term view. Here's an example. More